Company Overview of REN Pharmaceuticals, Inc.
REN Pharmaceuticals, Inc. develops and markets therapeutics for renal and associated cardio-renal diseases. The company offers data and useful reagents, including antibodies and recombinant proteins for studying the biology of renalase. Its products are used in the prevention and treatment of kidney disease and associated comorbid conditions. REN Pharmaceuticals, Inc. was founded in 2006 and is based in South San Francisco, California.
270 East Grand Avenue
South San Francisco, CA 94080
Founded in 2006
Key Executives for REN Pharmaceuticals, Inc.
REN Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact REN Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.